8-K: Cannabist Co. Secures $25.75 Million Through Convertible Note Offering

Sentiment:

Debt Financing Announcement


The Cannabist Company Holdings Inc. has successfully raised US$25.75 million through a private offering of senior secured convertible notes to repay debt and for general corporate purposes.

Capital raiseThe company is raising US$25.75 million through a private offering of senior secured convertible notes.The offering includes both new notes and exchange notes for existing debt.The company expects to receive approximately US$15.6 million in gross proceeds from the new notes after the discount.

Summary

  • The Cannabist Company Holdings Inc. has entered into subscription agreements with institutional investors to sell US$25.75 million in 9.00% senior secured convertible notes due in 2027.
  • The offering was split into a brokered and non-brokered private placement.
  • The notes were issued at an original issue discount of US$800 per US$1,000 in principal amount.
  • US$19.5 million of the notes were new notes, and US$6.25 million were exchange notes, swapping out US$5.0 million of existing 6.0% senior secured convertible notes due June 2025.
  • The company expects to receive approximately US$15.6 million in gross proceeds from the new notes after the discount.
  • The net proceeds will be used to repay US$13.2 million of 13% senior secured notes due May 2024, for working capital, and for general corporate purposes.
  • The notes bear interest at 9.00% per year, payable semi-annually on March 31 and September 30, starting September 30, 2024.
  • The notes are convertible into common shares at a price of US$0.305 per share, equivalent to approximately 3,278.6 shares per US$1,000 principal amount of notes.
  • The conversion price is subject to customary anti-dilution adjustments.
  • In the event of a change of control, holders may require the company to repurchase their notes at 101% of the principal amount plus accrued interest.

Sentiment

Score: 6

Explanation: The document is neutral to slightly positive. While the company is taking on more debt, it is also addressing existing debt and securing funds for operations. The convertible feature adds a potential upside, but the high interest rate and discount are concerning.

Positives

  • The company has successfully raised a significant amount of capital.
  • The funds will be used to reduce existing debt, improving the company's financial position.
  • The convertible feature of the notes could be attractive to investors.
  • The interest rate is fixed at 9.00%, providing certainty for the company.

Negatives

  • The notes were issued at a significant discount, reducing the net proceeds.
  • The conversion of notes could dilute existing shareholders.
  • The company is taking on more debt, albeit with a lower interest rate than the debt being repaid.
  • The company is relying on private placements, which may not be as stable as public markets.

Risks

  • The company's ability to repay the notes depends on its future financial performance.
  • The conversion of notes could significantly dilute existing shareholders.
  • The company's reliance on debt financing could increase its financial risk.
  • The cannabis industry is subject to regulatory and market risks.

Future Outlook

The company intends to use the net proceeds from the sale of the notes for the repayment of existing indebtedness, working capital, and general corporate purposes. The notes mature in March 2027, unless converted, redeemed, or repurchased earlier.

Industry Context

The cannabis industry is known for its volatile nature and high capital requirements. This financing move is typical for companies in this sector seeking to fund operations and growth while managing debt.

Comparison to Industry Standards

  • Many cannabis companies have used convertible debt to raise capital, as it offers flexibility and potential upside for investors.
  • The 9% interest rate is relatively high, reflecting the risk associated with the cannabis industry and the company's financial situation.
  • The conversion price of US$0.305 per share will be a key factor in determining the success of the offering, as it will influence the likelihood of conversion and potential dilution.
  • Companies like Aurora Cannabis and Tilray have also used convertible notes, but their terms and conditions vary based on their specific financial situations and market conditions.

Stakeholder Impact

  • Shareholders may experience dilution if the notes are converted into common shares.
  • Creditors will be repaid with the proceeds from the note offering.
  • Employees may benefit from the company's improved financial stability.
  • Customers and suppliers may see continued operations and services.

Next Steps

  • The company will use the proceeds to repay existing debt and fund operations.
  • The company will make semi-annual interest payments on the notes starting September 30, 2024.
  • The company will monitor the conversion of notes into common shares.
  • The company will manage its debt obligations and financial performance.

Key Dates

DateDescription
2020-05-14Date of the original trust indenture with Odyssey Trust Company.
2020-06-19Date of the first supplemental trust indenture.
2021-06-29Date of the second supplemental trust indenture.
2022-02-02Date of the third supplemental trust indenture.
2022-02-03Date of the fourth supplemental trust indenture.
2022-05-05Date of the fifth supplemental trust indenture.
2023-09-20Date of the sixth supplemental trust indenture.
2024-03-14Date of the 8-K filing.
2024-03-15Approximate date the company entered into subscription agreements.
2024-03-19Date of the seventh supplemental indenture and closing of the offerings.
2024-03-20Date the 8-K report was signed.
2024-09-30First interest payment date for the new notes.
2027-03-19Maturity date of the convertible notes.

Keywords

convertible notes, debt financing, capital raise, cannabis, senior secured notes, private placement, institutional investors, debt repayment, working capital

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.